Showing results (121-130 of 155) with videos related to
Sort By:
Pageof 16
Clinical & Experimental Metastasis|August 18, 2021
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212Kenji Katsumata, Masanobu Enomoto, Tetsuo Ishizaki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2021
Hepatectomy Followed by mFOLFOX6 Versus Hepatectomy Alone for Liver-Only Metastatic Colorectal Cancer (JCOG0603): A Phase II or III Randomized Controlled TrialYukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.Annals of Gastroenterological Surgery|July 18, 2022
Safety, efficacy, and operability of a newly developed absorbable adhesion barrier (GM142) in patients with primary rectal cancer scheduled for diverting ileostomy during laparoscopic surgery: Randomized controlled trialJun Watanabe, Shigeki Yamaguchi, Ichiro Takemasa, et al.Japanese Journal of Clinical Oncology|May 22, 2025
Protocol digest of a single-arm confirmatory trial for less intensive postoperative surveillance in low-risk colorectal cancer patients: JCOG1915 (less study)Yuta Sekino, Konosuke Moritani, Junki Mizusawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2026
Randomized Phase II/III Trial Comparing Hepatectomy, Followed by mFOLFOX6 With Hepatectomy Alone for Liver Metastasis From Colorectal Cancer: Long-Term Results of JCOG0603Yukihide Kanemitsu, Yasuhiro Shimizu, Junki Mizusawa, et al.Annals of Surgery|August 8, 2023
Prognostic Relevance of Primary Tumor Sidedness in Early-stage Colorectal Cancer: An Integrated Analysis of 4 Randomized Controlled Trials (JCOG2003A)Akira Ouchi, Ryo Sadachi, Tetsuya Hamaguchi, et al.International Journal of Clinical Oncology|June 9, 2026
A multicenter survey on BRAF screening for the implementation of perioperative cancer genomic medicine for resectable colorectal oligometastasesShin Kobayashi, Nobuhisa Matsuhashi, Yusuke Suwa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 9, 2021
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical TrialYukihide Kanemitsu, Kohei Shitara, Junki Mizusawa, et al.European Journal of Cancer (Oxford, England : 1990)|November 23, 2024
Sex differences in toxicities and survival outcomes among Japanese patients with Stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of 4 randomized controlled trials (JCOG2310A)Hidekazu Hirano, Kozo Kataoka, Toshifumi Yamaguchi, et al.Journal of Radiation Research|July 17, 2020
Effect of preoperative chemoradiotherapy on the immunological status of rectal cancer patientsKazuaki Yasui, Ryota Kondou, Akira Iizuka, et al.Pageof 16